Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Polman

Showing results (61-70 of 290) with videos related to

Pageof 29
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|March 18, 2003
One year changes in disability in multiple sclerosis: neurological examination compared with patient self reportE L J Hoogervorst, M J Eikelenboom, B M J Uitdehaag, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 10, 2014
Disease course heterogeneity and OCT in multiple sclerosisL J Balk, P Tewarie, J Killestein, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2008
At the heart of primary progressive multiple sclerosis: three cases with diffuse MRI abnormalities onlyJ N P Zwemmer, J C J Bot, B Jelles, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 3, 2007
[Immunomodulatory therapy in multiple sclerosis]B M J Uitdehaag, B Jelles, J Killestein, et al.
Archives of Neurology|May 1, 1990
Accuracy and interobserver variation in the interpretation of computed tomography in solitary brain lesionsJ J Heimans, M De Visser, C H Polman, et al.
Journal of Neurology|January 1, 1987
Cerebrospinal fluid cells in multiple sclerosis and other neurological diseases: an immunocytochemical studyC H Polman, C J de Groot, J C Koetsier, et al.
Immunobiology|January 1, 1987
Macrophages in the central nervous system of the ratT Sminia, C J de Groot, C D Dijkstra, et al.
European Journal of Neurology|April 21, 1999
Cardiovascular autonomic function in patients with relapsing remitting multiple sclerosis: a new surrogate marker of disease evolution?K Nasseri, B M Uitdehaag, M A van Walderveen, et al.
Neurology|September 18, 2007
Postwithdrawal rebound increase in T2 lesional activity in natalizumab-treated MS patientsM M Vellinga, J A Castelijns, F Barkhof, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 29, 2001
Differential treatment effect on measures of neurologic exam, functional impairment and patient self-report in multiple sclerosisE L Hoogervorst, N F Kalkers, van Winsen LML, et al.
Pageof 29

Showing results (61-70 of 290) with videos related to

Sort By:
Pageof 29
Journal of Neurology, Neurosurgery, and Psychiatry|March 18, 2003
One year changes in disability in multiple sclerosis: neurological examination compared with patient self reportE L J Hoogervorst, M J Eikelenboom, B M J Uitdehaag, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 10, 2014
Disease course heterogeneity and OCT in multiple sclerosisL J Balk, P Tewarie, J Killestein, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2008
At the heart of primary progressive multiple sclerosis: three cases with diffuse MRI abnormalities onlyJ N P Zwemmer, J C J Bot, B Jelles, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 3, 2007
[Immunomodulatory therapy in multiple sclerosis]B M J Uitdehaag, B Jelles, J Killestein, et al.
Archives of Neurology|May 1, 1990
Accuracy and interobserver variation in the interpretation of computed tomography in solitary brain lesionsJ J Heimans, M De Visser, C H Polman, et al.
Journal of Neurology|January 1, 1987
Cerebrospinal fluid cells in multiple sclerosis and other neurological diseases: an immunocytochemical studyC H Polman, C J de Groot, J C Koetsier, et al.
Immunobiology|January 1, 1987
Macrophages in the central nervous system of the ratT Sminia, C J de Groot, C D Dijkstra, et al.
European Journal of Neurology|April 21, 1999
Cardiovascular autonomic function in patients with relapsing remitting multiple sclerosis: a new surrogate marker of disease evolution?K Nasseri, B M Uitdehaag, M A van Walderveen, et al.
Neurology|September 18, 2007
Postwithdrawal rebound increase in T2 lesional activity in natalizumab-treated MS patientsM M Vellinga, J A Castelijns, F Barkhof, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 29, 2001
Differential treatment effect on measures of neurologic exam, functional impairment and patient self-report in multiple sclerosisE L Hoogervorst, N F Kalkers, van Winsen LML, et al.
Pageof 29